Yes To $14 mil
This article was originally published in The Rose Sheet
Executive Summary
Yes To Inc., an Israeli consumer products firm that markets Yes To Carrots personal care, has raised $14 mil. in a series-A funding round to expand distribution in North America and speed up the firm's product launch schedule, company announces July 29. Yes To Carrots, a collection of skin- and hair-care items juiced with beta carotene from orange-colored organic fruits and vegetables and further enriched with Dead Sea minerals, launched overseas in 2006 and has been sold primarily by Walgreens in the U.S. since May 2007. In addition to taking brand to new sellers in the U.S., company will use capital to roll out Yes To Cucumbers and Yes To Tomatoes later this year. "Natural paraben-free formulations, high efficacy and a fun brand personality" are attributes that resonate with consumers and have contributed to "exponential" growth of the line, says Scott Potter, managing partner of San Francisco Equity Partners, which led the financing round. Simon Equity Partners also participated. USDA-certified organic Yes To Carrots lip balms launched earlier this summer (1"The Rose Sheet" July 7, 2008, p. 5)...
You may also be interested in...
Yes To Carrots Unveils USDA-Certified Organic Lip Balms With Beta-Carotene
Yes To Carrots adds USDA-certified organic lip balms to its range of organic hair-, body- and skin-care products enriched with beta-carotene, found in orange fruits and vegetables
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.